Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Breier

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|August 10, 2024
Gaining trust through transparency: the EMERGENT-2 trial - Authors' replyInder Kaul, Alan Breier, Andrew C Miller, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophreniaIgor Elman, Scott Lukas, Susan E Shoaf, et al.
Schizophrenia Research|September 21, 2015
Intrinsic motivation and amotivation in first episode and prolonged psychosisLauren Luther, Paul H Lysaker, Ruth L Firmin, et al.
Translational Psychiatry|February 7, 2025
Methods to address functional unblinding of raters in CNS trialsSteven D Targum, William P Horan, Vicki G Davis, et al.
Biological Psychiatry|March 27, 2024
Muscarinic Receptor Activators as Novel Treatments for SchizophreniaSteven M Paul, Samantha E Yohn, Stephen K Brannan, et al.
Journal of Abnormal Psychology|March 22, 2016
Affective systems induce formal thought disorder in early-stage psychosisKyle S Minor, Matthew P Marggraf, Beshaun J Davis, et al.
Schizophrenia Research|April 17, 2026
Factor analysis of two COMPASS psychopathology symptom scales for first-episode psychosisCraig R Miller, Stephan F Taylor, Alan Breier, et al.
Psychiatry Research|January 23, 2022
Semantic and phonetic similarity of verbal fluency responses in early-stage psychosisNancy B Lundin, Michael N Jones, Evan J Myers, et al.
The Journal of Clinical Psychiatry|August 28, 2024
Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in SchizophreniaBruce J Kinon, Stefan Leucht, Carol Tamminga, et al.
Human Psychopharmacology|March 6, 2008
Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorderDavid H Adams, Sandra Close, Mark Farmen, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|August 10, 2024
Gaining trust through transparency: the EMERGENT-2 trial - Authors' replyInder Kaul, Alan Breier, Andrew C Miller, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophreniaIgor Elman, Scott Lukas, Susan E Shoaf, et al.
Schizophrenia Research|September 21, 2015
Intrinsic motivation and amotivation in first episode and prolonged psychosisLauren Luther, Paul H Lysaker, Ruth L Firmin, et al.
Translational Psychiatry|February 7, 2025
Methods to address functional unblinding of raters in CNS trialsSteven D Targum, William P Horan, Vicki G Davis, et al.
Biological Psychiatry|March 27, 2024
Muscarinic Receptor Activators as Novel Treatments for SchizophreniaSteven M Paul, Samantha E Yohn, Stephen K Brannan, et al.
Journal of Abnormal Psychology|March 22, 2016
Affective systems induce formal thought disorder in early-stage psychosisKyle S Minor, Matthew P Marggraf, Beshaun J Davis, et al.
Schizophrenia Research|April 17, 2026
Factor analysis of two COMPASS psychopathology symptom scales for first-episode psychosisCraig R Miller, Stephan F Taylor, Alan Breier, et al.
Psychiatry Research|January 23, 2022
Semantic and phonetic similarity of verbal fluency responses in early-stage psychosisNancy B Lundin, Michael N Jones, Evan J Myers, et al.
The Journal of Clinical Psychiatry|August 28, 2024
Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in SchizophreniaBruce J Kinon, Stefan Leucht, Carol Tamminga, et al.
Human Psychopharmacology|March 6, 2008
Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorderDavid H Adams, Sandra Close, Mark Farmen, et al.
Pageof 11